Sourcing OSI 906?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Imetelstat
pharmaceutical raw material
Sourcing OSI 906?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
OSI 906, also known as linsitinib, is an experimental drug candidate that inhibits the insulin receptor and insulin-like growth factor 1 receptor (IGF-1R). It is primarily used in cancer research for its ability to prevent tumor cell proliferation and induce apoptosis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
The international HS code for OSI 906 (CAS 867160-71-2) is 2933.49.
2933.49
2933 49 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
3-[8-amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl]-1-methylcyclobutan-1-ol
PKCDDUHJAFVJJB-UHFFFAOYSA-N
CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O